phase readout
saveNCT06631079: Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors
ACTIVE_NOT_RECRUITINGupdated 4d ago
community read0 votes
Sponsor: NEC Bio B.V. Phase: PHASE1. Conditions: Solid Tumor
view source ↗
comments(0)
5-min edit window · permanent after that